IN8bio, Inc.

NasdaqGM:INAB Stock Report

Market Cap: US$19.6m

IN8bio Management

Management criteria checks 2/4

IN8bio's CEO is William Ho, appointed in Nov 2015, has a tenure of 9.08 years. total yearly compensation is $1.85M, comprised of 30.8% salary and 69.2% bonuses, including company stock and options. directly owns 3.87% of the company’s shares, worth $756.97K. The average tenure of the management team and the board of directors is 5 years and 4.3 years respectively.

Key information

William Ho

Chief executive officer

US$1.9m

Total compensation

CEO salary percentage30.8%
CEO tenure9.1yrs
CEO ownership3.9%
Management average tenure5yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

IN8bio (NASDAQ:INAB) Will Have To Spend Its Cash Wisely

Aug 06
IN8bio (NASDAQ:INAB) Will Have To Spend Its Cash Wisely

We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate

Apr 03
We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate

Companies Like IN8bio (NASDAQ:INAB) Could Be Quite Risky

Nov 04
Companies Like IN8bio (NASDAQ:INAB) Could Be Quite Risky

Is IN8bio (NASDAQ:INAB) In A Good Position To Invest In Growth?

Jan 26
Is IN8bio (NASDAQ:INAB) In A Good Position To Invest In Growth?

Here's Why We're Watching IN8bio's (NASDAQ:INAB) Cash Burn Situation

Oct 12
Here's Why We're Watching IN8bio's (NASDAQ:INAB) Cash Burn Situation

IN8bio gains 53% as H.C. Wainwright initiates with Buy

Aug 30

IN8bio raises additional funds from underwriter of stock offering

Aug 19

IN8bio prices $10.25M stock offering

Aug 12

We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate

Jun 04
We're Keeping An Eye On IN8bio's (NASDAQ:INAB) Cash Burn Rate

IN8bio (NASDAQ:INAB) Is In A Good Position To Deliver On Growth Plans

Feb 13
IN8bio (NASDAQ:INAB) Is In A Good Position To Deliver On Growth Plans

IPO Update: IN8bio Aims For Downsized IPO

Jul 29

CEO Compensation Analysis

How has William Ho's remuneration changed compared to IN8bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$32m

Jun 30 2024n/an/a

-US$32m

Mar 31 2024n/an/a

-US$31m

Dec 31 2023US$2mUS$572k

-US$30m

Sep 30 2023n/an/a

-US$30m

Jun 30 2023n/an/a

-US$30m

Mar 31 2023n/an/a

-US$30m

Dec 31 2022US$2mUS$550k

-US$29m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$23m

Mar 31 2022n/an/a

-US$18m

Dec 31 2021US$2mUS$446k

-US$15m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$1mUS$279k

-US$10m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$6m

Dec 31 2019US$214kUS$214k

-US$6m

Compensation vs Market: William's total compensation ($USD1.85M) is above average for companies of similar size in the US market ($USD646.54K).

Compensation vs Earnings: William's compensation has increased whilst the company is unprofitable.

CEO

William Ho (47 yo)

9.1yrs

Tenure

US$1,854,166

Compensation

Mr. William Ho, also known as Will, is the Co-Founder of IN8bio, Inc. and has been President, Chief Executive Officer and Director since November 2015 and had been its Chief Financial Officer since October...

Leadership Team

NamePositionTenureCompensationOwnership
Tai-Wei Ho
Co-Founder9.1yrsUS$1.85m3.87%
$ 757.0k
Patrick McCall
CFO & Secretary3.8yrsUS$914.84k0.072%
$ 14.1k
Lawrence Lamb
Executive VP6.1yrsUS$918.75k0.14%
$ 27.4k
Kate Rochlin
Chief Operating Officer4yrsUS$934.68k0.059%
$ 11.6k

5.0yrs

Average Tenure

44.5yo

Average Age

Experienced Management: INAB's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Tai-Wei Ho
Co-Founder9.1yrsUS$1.85m3.87%
$ 757.0k
Peter Brandt
Independent Director5.3yrsUS$195.42k0.86%
$ 168.2k
Alan Roemer
Independent Chairman of the Board4.3yrsUS$256.42k0.39%
$ 77.0k
Emily Fairbairn
Independent Director3.4yrsUS$172.92k4.61%
$ 902.2k
Marcela Maus
Member of Scientific Advisory Boardno datano datano data
Travis Whitfill
Independent Director4.3yrsUS$163.67k0%
$ 0
Luba Greenwood
Independent Director3.4yrsUS$181.42k0.011%
$ 2.1k
Bruce Levine
Member of Scientific Advisory Boardno datano datano data
Siraj Ali
Member of Scientific Advisory Boardno datano datano data
Bianca Santomasso
Member of Scientific Advisory Boardno datano datano data
Dieter Kabelitz
Member of Scientific Advisory boardno datano datano data
Michael Bishop
Member of Scientific Advisory Board2.3yrsno datano data

4.3yrs

Average Tenure

47yo

Average Age

Experienced Board: INAB's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 05:23
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IN8bio, Inc. is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kalpit PatelB. Riley Securities, Inc.
Swayampakula RamakanthH.C. Wainwright & Co.
Soumit RoyJonesTrading Institutional Services, LLC